People | March 28, 2026
Shreehas Tambe appointed CEO & Managing Director of Biocon
Kedar Upadhye has also been appointed as Chief Financial Officer of Biocon Limited
Kedar Upadhye has also been appointed as Chief Financial Officer of Biocon Limited
The move leverages Novartis’ deep expertise in IgE biology and long-standing presence in allergic disease treatments
Otsuka will pay $700 million to Transcend shareholders at closing, with an additional $525 million in contingent payments tied to future sales milestones
Paroxetine extended-release tablets are indicated for the treatment of major depressive disorder
The milestone moves the company closer to its previously announced $120 million US expansion, with groundbreaking slated for late 2026
TERN-701, a next-generation therapy targeting chronic myeloid leukemia (CML), a form of blood cancer that still presents treatment challenges despite decades of advances
The collaboration will see HNL Lab Medicine deploy Ibex’s cutting-edge AI solution, Ibex Prostate, for biopsies and transurethral resection of the prostate (TURP), boosting both diagnostic accuracy and workflow efficiency
SNV4818, the oral drug, is pan-mutant–selective PI3K? inhibitor aimed at treating HR+/HER2- breast cancer and potentially other solid tumors
The radiotherapy systems include TrueBeam, TrueBeam STx, VitalBeam, and Edge
Vapendavir is an oral, potent, broad-spectrum antiviral active against rhinoviruses and related respiratory enteroviruses
Subscribe To Our Newsletter & Stay Updated
